Jutta Kath to Chair ISC Switzerland

Jutta Kath, formerly of insurance-linked securities (ILS) specialist manager Schroder Secquaero, has been appointed as Chair of ISC Switzerland, the countries branch of the well-known global insurance and reinsurance business community for women. Kath departed from Schroder Secquaero this year and has since launched her own company focused on leadership and motivational coaching, and continued…

Read More

Arch Re hires Brian Lynch from Aon for ILS & retro operations role

Arch Re, the reinsurance underwriting arm of specialty re/insurer Arch Capital Group in Bermuda, has hired Brian Lynch from Aon’s insurance management unit for an operational role focused on insurance-linked securities and retrocession. Arch Re leverages retrocessional reinsurance for its own book and also shares risks with third-party investors through insurance-linked securities (ILS) style structures.…

Read More

Tony Maximchuk joins Twelve Capital UK as non-exec director

Twelve Capital, the Zurich headquartered catastrophe bond, insurance-linked securities (ILS) and reinsurance linked investment fund manager, has appointed well-known ILS exec Tony Maximchuk as a Non-Executive Director for its Twelve Capital (UK) Limited operation. Tony Maximchuk was most recently employed by London-headquartered ILS and reinsurance linked asset manager Securis Investment Partners but retired from the…

Read More

ESG has huge strategic relevance for risk transfer & ILS markets, survey finds

During the third-quarter of 2020 we teamed up with boutique consulting firm Synpulse to conduct a survey looking at the maturity of environmental, social, and governance (ESG) adoption in the risk transfer, reinsurance and insurance-linked securities (ILS) markets. This was the first environmental, social, and governance (ESG) survey of its kind, looking at how companies…

Read More

Stocks Hit New 52-Week On Moderna’s Coronavirus Vaccine Results

stocks hit new 52-week Moderna Coronavirus Vaccine more Covid Victims senate negotiation Eli Lilly Antibody Treatment big Coronavirus stimulus checks $1.8T Pandemic Lessons deal coronavirus stimulus checks Biden Kamala Harris Vaccine digital job training $1 trillion coronavirus relief package

Commenting on Moderna’s Coronavirus vaccine and with stocks hitting new 52-week highs in today’s trading, Gorilla Trades strategist Ken Berman said: Q3 2020 hedge fund letters, conferences and more Moderna’s Promising Coronavirus Vaccine Announcement The major indices are all trading significantly higher at midday, with the Dow and the S&P 500 gaining the most ground. […]

The post Stocks Hit New 52-Week On Moderna’s Coronavirus Vaccine Results appeared first on ValueWalk.

Read More

Moderna Covid Vaccine Maybe Not 94.4% Effective

moderna covid-19 vaccine

Moderna Covid Vaccine Maybe Not 94.4% Effective; Epidemiologists Can’t Infer Precise Results From Tiny Sample Size Q3 2020 hedge fund letters, conferences and more Moderna’s Claims For Covid Vaccine Effectiveness Might Be Misleading WASHINGTON, D.C. (November 16, 2020) – “Moderna’s COVID-19 Vaccine Is 94.5% effective” say many headlines, but claiming the precise effectiveness, supposedly accurate […]

The post Moderna Covid Vaccine Maybe Not 94.4% Effective appeared first on ValueWalk.

Read More

Will Lyft Ever Pay A Dividend?

Lyft, Inc. (LYFT) made its widely-expected initial public offering, or IPO, in March-2019 at a price of $72. Since then, the stock has plunged 47% and has disappointed its investors due to its dramatic under-performance compared to the broad market. Approximately half of the decline of the stock price has occurred due to the coronavirus…

Read More